CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Immuron Limited Company Snapshot
Immuron Limited operates within the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Immuron Limited with three other pharmaceutical manufacturers in Australasia: Adalta Ltd (2016 sales of 878,394.00 Australian Dollars [US$668,993.65 ] ), Paradigm Biopharmaceuticals Ltd (1.39 million Australian Dollars [US$1.06 million] ), and Orthocell Ltd (1.19 million Australian Dollars [US$904,192.53 ] ).

Sales Analysis. During the year ended June of 2016, sales at Immuron Limited were A$1.16 million (US$880.06 thousand). This is an increase of 2.8% versus 2015, when the company's sales were A$1.12 million. This was the third consecutive year of growth at Immuron Limited.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Immuron Limited
  Stock Performance Chart for Immuron Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (3/24/2017): .38
(Figures in Australian Dollars)
1 Week 26.7%   13 Weeks 22.6%  
4 Weeks 35.7%   52 Weeks -4.1%  
 
Immuron Limited Key Data:
  Ticker: IMC Country: Australia
  Exchanges: OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2016 Sales 1,155,523
(Year Ending Jan 2017).
Employees: 25
  Currency: Australian Dollars Market Cap: 40,143,738
  Fiscal Yr Ends: June Shares Outstanding: 105,641,417
  Share Type: Ordinary Closely Held Shares: 52,570,412
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.